HLA-E genotype was overall significantly associated with DFS probability, whereas the impact on other clinical outcome endpoints did not reach statistical significance (data not shown), with the exception of relapse incidence, where a trend was detected.
← all excerpts
Donor HLA-E Status Associates with Disease-Free Survival and Transplant-Related Mortality after Non In Vivo T Cell-Depleted HSCT for Acute Leukemia.
1
—
—